SEC Filings TLDR

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.

2025-10-07WOLFSCHEDULE 13GFMR LLC's Schedule 13G Filing for Wolfspeed Inc.MEDIUM
FMR LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 12.4% of Wolfspeed Inc.'s common stock, amounting to 3,210,752 shares. The filing indicates that FMR LLC has sole voting power over 3,131,601 shares and sole dispositive power over all 3,210,752 shares. The filing also mentions that Abigail P. J...
2025-10-07WOLFSCHEDULE 13GT. Rowe Price Associates, Inc. Reports 14.8% Ownership in Wolfspeed Inc.MEDIUM
T. Rowe Price Associates, Inc. has filed a Schedule 13G with the SEC, reporting a 14.8% ownership in Wolfspeed Inc. as of September 30, 2025. The filing indicates that T. Rowe Price Associates, Inc. beneficially owns 4,228,383 shares of Wolfspeed's common stock, with sole voting power over 1,525,456 shares and sole dis...
2025-10-07TENXSCHEDULE 13GIkarian Capital and Neil Shahrestani's Schedule 13G Filing for Tenax TherapeuticsMEDIUM
Ikarian Capital, LLC and Neil Shahrestani have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 967,600 shares of Tenax Therapeutics, Inc. common stock, representing 21.2% of the outstanding shares. Ikarian Capital, an investment adviser registered under the Investment Advisers Act of...
2025-10-07TIXTSCHEDULE 13GFIL Limited's Schedule 13G Filing for TELUS INTERNATIONAL CDA INCMEDIUM
FIL Limited has filed a Schedule 13G with the SEC, disclosing its ownership of 13,123,363 Subordinate Voting Shares of TELUS INTERNATIONAL CDA INC, representing 11.5% of the total outstanding shares. The filing indicates that FIL Limited has sole voting and dispositive power over these shares. Additionally, the filing ...
2025-10-07ASSTSCHEDULE 13GYA II PN, Ltd. Reports 9.9% Beneficial Ownership in Strive, Inc.MEDIUM
YA II PN, Ltd., along with its affiliates, has reported a 9.9% beneficial ownership in Strive, Inc. The ownership includes 17,250,000 shares of Class A Common Stock and 21,326,603 additional shares acquirable through warrants, subject to a blocker preventing exercise that would cause YA II to exceed 9.99%. The filing, ...
2025-10-07PAYSCHEDULE 13GWasatch Advisors LP's 13G Filing for Paymentus Holdings IncMEDIUM
Wasatch Advisors LP has filed a Schedule 13G with the SEC, disclosing its ownership of 4,694,109 shares of Paymentus Holdings Inc's Class A common stock, representing 10.4% of the total shares outstanding. The filing indicates that Wasatch Advisors LP has sole voting power over 3,368,638 shares and sole dispositive pow...
2025-10-07PALISCHEDULE 13GPoint72 Asset Management's 6.2% Stake in Palisade Bio, Inc.MEDIUM
Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing a 6.2% beneficial ownership in Palisade Bio, Inc. The filing, dated October 6, 2025, indicates that Point72 Asset Management maintains investment and voting power over the share...
2025-10-07OPALSCHEDULE 13GInvesco Ltd. Reports 10.1% Ownership in OPAL Fuels IncMEDIUM
Invesco Ltd. has filed a Schedule 13G with the SEC, reporting a 10.1% ownership in OPAL Fuels Inc. The filing indicates that Invesco Ltd., as a parent holding company to its investment advisers, may be deemed to beneficially own 2,937,645 shares of OPAL Fuels Inc. These shares are held by clients of Invesco Ltd. The fi...
2025-10-07LMBSCHEDULE 13GThrivent Financial for Lutherans' Schedule 13G Filing for Limbach Holdings, Inc.MEDIUM
Thrivent Financial for Lutherans filed a Schedule 13G with the SEC, disclosing its ownership of 735,121 shares of Limbach Holdings, Inc., representing 6.32% of the company's outstanding common stock. The filing indicates that Thrivent Financial for Lutherans serves as the investment adviser for registered investment co...
2025-10-07LPBBSCHEDULE 13GBANK OF NOVA SCOTIA's Schedule 13G Filing for Launch Two Acquisition Corp.MEDIUM
BANK OF NOVA SCOTIA has filed a Schedule 13G with the SEC, disclosing its ownership of 1,296,800 Class A Ordinary Shares of Launch Two Acquisition Corp., representing 5.64% of the total shares. The filing indicates that BANK OF NOVA SCOTIA has sole voting and dispositive power over these shares. The filing was made und...
2025-10-07JZXNSCHEDULE 13GS.H.N. Financial Investments Ltd. Reports 9.99% Ownership in Jiuzi Holdings, Inc.MEDIUM
S.H.N. Financial Investments Ltd. has filed a Schedule 13G with the SEC, reporting a 9.99% ownership in Jiuzi Holdings, Inc. The filing indicates that S.H.N. Financial Investments Ltd. beneficially owns 2,023,000 ordinary shares of Jiuzi Holdings, Inc., which includes 2,000,000 ordinary shares and 23,000 warrants to pu...
2025-10-07JZXNSCHEDULE 13GL1 Capital Global Opportunities Master Fund, Ltd. Reports 9.99% Ownership in Jiuzi Holdings, Inc.MEDIUM
L1 Capital Global Opportunities Master Fund, Ltd. has filed a Schedule 13G with the SEC, reporting a 9.99% beneficial ownership in Jiuzi Holdings, Inc. The filing indicates that L1 Capital owns 2,023,000 Ordinary Shares, including 2,000,000 Ordinary Shares and 23,000 Warrants to purchase Ordinary Shares. The filing als...
2025-10-07Invesco Ltd.SCHEDULE 13GInvesco Ltd. Schedule 13G Filing for OPAL Fuels IncMEDIUMDuplicateded
Invesco Ltd. filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 10.1% of OPAL Fuels Inc's common stock, amounting to 2,937,645 shares. The filing indicates that Invesco Ltd., as a parent holding company, may be deemed to beneficially own these shares, which are held by its clients. The filing als...
2025-10-07IMRXSCHEDULE 13GFMR LLC's Schedule 13G Filing for Immuneering CorpMEDIUM
FMR LLC filed a Schedule 13G with the SEC, disclosing its ownership of 14.5% of the Class A Common Stock of Immuneering Corp. The filing indicates that FMR LLC beneficially owns 8,787,052 shares, with sole voting power over 8,780,283 shares and sole dispositive power over all 8,787,052 shares. The filing also mentions ...
2025-10-07ORBSSCHEDULE 13GSchedule 13G Filing for Eightco Holdings Inc. by Wedbush Alpha One ORBS T1, LLC and Alpha One Asset Management, LLCMEDIUM
Wedbush Alpha One ORBS T1, LLC and Alpha One Asset Management, LLC have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 11,643,836 shares of common stock in Eightco Holdings Inc., representing 6.4% of the outstanding shares. The filing indicates that both entities have sole voting and dispos...
2025-10-07CURRSCHEDULE 13GWong Man San's Schedule 13G Filing for Currenc Group Inc.LOW
Wong Man San, a citizen of Hong Kong, has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 3,795,837 common shares of Currenc Group Inc., representing 4.98% of the company's outstanding shares. The filing indicates that Wong Man San has sole voting and dispositive power over these shares. The share...
2025-10-07CCCXWSCHEDULE 13GMerus Global Investments, LLC's Ownership in Churchill Capital Corp XLOW
Merus Global Investments, LLC has reported ownership of 1,776,660 Class A ordinary shares of Churchill Capital Corp X, representing 4.3% of the total outstanding shares. The filing, submitted under Rule 13d-1(c), indicates that the shares were not acquired for the purpose of influencing the control of the issuer. The s...
2025-10-07CHRSCHEDULE 13GBigger Capital Fund's Ownership in Cheer Holding, Inc.MEDIUM
Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and Michael Bigger, filed a Schedule 13G on October 7, 2025, disclosing their ownership in Cheer Holding, Inc. As of October 2, 2025, each entity and individual beneficially owned approximately 7.09% of the Class A Ordinary Shares. How...
2025-10-07CAMPSCHEDULE 13GFMR LLC's Schedule 13G Filing for Camp4 Therapeutics CorpMEDIUM
FMR LLC filed a Schedule 13G with the SEC, disclosing its ownership of 15% of the common stock of Camp4 Therapeutics Corp. The filing indicates that FMR LLC beneficially owns 3,023,434 shares, with sole voting power over 3,022,105 shares and sole dispositive power over all 3,023,434 shares. The filing also mentions tha...
2025-10-07BREASCHEDULE 13GARK Investment Management LLC and Catherine D. Wood Schedule 13G Filing for Brera Holdings PLCMEDIUM
ARK Investment Management LLC and Catherine D. Wood have filed a Schedule 13G with the SEC, disclosing their ownership of Class B Ordinary Shares in Brera Holdings PLC. ARK Investment Management LLC, a Delaware-based investment advisor, and Catherine D. Wood, its Chief Executive Officer and Chief Investment Officer, co...
2025-10-07BSLKWSCHEDULE 13GSchedule 13G Filing for Bolt Projects Holdings, Inc.MEDIUM
The Schedule 13G filing discloses the beneficial ownership of common stock in Bolt Projects Holdings, Inc. by a group of reporting persons, including Ascent Partners Fund LLC, Ascent Partners LLC, Dominion Capital LLC, Dominion Capital GP LLC, Dominion Capital Holdings LLC, Masada Group Holdings LLC, Mikhail Gurevich, ...
2025-10-07BYONSCHEDULE 13GJane Street Group's 13G Filing for Bed Bath & BeyondMEDIUM
Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC, Jane Street Options, LLC, and Jane Street Global Trading, LLC, filed a Schedule 13G with the SEC, disclosing their ownership of 5.1% of Bed Bath & Beyond's common stock. The filing indicates that Jane Street Group, LLC holds 2,910,102 shares,...
2025-10-07BANK OF NOVA SCOTIASCHEDULE 13GBANK OF NOVA SCOTIA's Schedule 13G Filing for Launch Two Acquisition Corp.MEDIUMDuplicateded
BANK OF NOVA SCOTIA filed a Schedule 13G with the SEC, disclosing its ownership of 1,296,800 Class A Ordinary Shares of Launch Two Acquisition Corp., representing 5.64% of the total shares. The filing indicates that BANK OF NOVA SCOTIA has sole voting and dispositive power over these shares. The filing was made under R...
2025-10-07AMLXSCHEDULE 13GFMR LLC's Schedule 13G Filing for Amylyx Pharmaceuticals IncMEDIUM
FMR LLC filed a Schedule 13G with the SEC, disclosing its ownership of 11,379,207 shares of common stock in Amylyx Pharmaceuticals Inc, representing 10.7% of the total outstanding shares. The filing indicates that FMR LLC has sole voting power over 11,361,910 shares and sole dispositive power over all 11,379,207 shares...
2025-10-07AKROSCHEDULE 13GDeep Track Capital, LP and Related Entities File Schedule 13G for Akero Therapeutics, Inc.MEDIUM
Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 4,400,000 shares of Akero Therapeutics, Inc. common stock, representing 5.50% of the outstanding shares. The filing indicates that the shares are held for ...